BMY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bristol-Myers Squibb Co (BMY) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock offers a strong dividend yield, has positive congressional trading sentiment, and shows potential for long-term growth despite short-term price weakness. The recent 3% year-over-year revenue increase and upcoming catalysts in the second half of 2026 further strengthen its appeal for long-term investors.
The MACD is negatively expanding (-0.128), indicating bearish momentum. RSI is at 28.583, suggesting the stock is nearing oversold territory. Moving averages are converging, showing no clear trend. Key support is at 54.093, with resistance at 57.436. The stock is trading near its support level, which could present a buying opportunity.
Congress members made two purchase transactions with a median amount of $1.6M, indicating positive sentiment.
The company reported a 3% year-over-year revenue increase in Q
Bristol-Myers offers a strong dividend yield, with a quarterly dividend of $0.63 per share declared for August 3,
Analysts have raised price targets, with Citi increasing it to $66 and Cantor Fitzgerald to $54.
Pharmaceutical stocks faced downward pressure due to proposed drug price negotiations by the Centers for Medicare and Medicaid Services.
The MACD and RSI suggest short-term bearish momentum.
The stock has a 90% chance of a -1.1% decline in the next day, indicating potential short-term weakness.
Bristol-Myers reported a 3% year-over-year revenue increase to $11.5 billion in Q1 2026, highlighting steady growth. However, no detailed financial snapshot or valuation data is available to assess profitability or other metrics.
Analysts have mixed ratings: Citi raised the price target to $66 with a Neutral rating, while BofA lowered the target to $67 but maintained a Buy rating. Cantor Fitzgerald raised the target to $54 with a Neutral rating, citing second-half 2026 catalysts as critical for growth.
